PDK2 and neoplasm: Dysfunction of complex I also leads to increased levels of α-ketoglutarate, alterations in Hypoxia-inducible factor-1α (HIF1α), generation of ROS, and activation of pyruvate dehydrogenase kinase 2 (PDK2), which accelerates tumor growth (24).